CENTOGENE to receive license fee providing Evotec with R&D license to complete next phase of pre-clinical researchCompanies amend existing drug discovery partnership for Evotec to lead continued development. Upon
Shares of Teledyne Technologies Incorporated (NYSE:TDY) fell sharply during Wednesday’s session after the company reported worse-than-expected first-quarter financial…